Muriel Duflos

846 total citations
48 papers, 732 citations indexed

About

Muriel Duflos is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Muriel Duflos has authored 48 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Organic Chemistry, 14 papers in Molecular Biology and 8 papers in Toxicology. Recurrent topics in Muriel Duflos's work include Synthesis and biological activity (15 papers), Synthesis and Biological Evaluation (13 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Muriel Duflos is often cited by papers focused on Synthesis and biological activity (15 papers), Synthesis and Biological Evaluation (13 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Muriel Duflos collaborates with scholars based in France, Germany and South Korea. Muriel Duflos's co-authors include Guillaume Le Baut, Marc Le Borgne, Pascal Marchand, Marie‐Renée Nourrisson, Thierry Besson, Fabrice Pagniez, Patrice Le Pape, Rolf W. Hartmann, Cédric Logé and Nadège Loaëc and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Tetrahedron.

In The Last Decade

Muriel Duflos

47 papers receiving 718 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muriel Duflos France 15 501 202 96 73 66 48 732
Konrad Kubiński Poland 15 302 0.6× 329 1.6× 69 0.7× 50 0.7× 85 1.3× 45 748
Aurélien Lesnard France 15 246 0.5× 325 1.6× 84 0.9× 25 0.3× 40 0.6× 27 571
Abid H. Banday India 13 410 0.8× 267 1.3× 42 0.4× 134 1.8× 56 0.8× 29 673
Sahar Kandil United Kingdom 12 280 0.6× 188 0.9× 26 0.3× 45 0.6× 25 0.4× 19 525
Eduardo Palomino United States 14 317 0.6× 195 1.0× 21 0.2× 82 1.1× 32 0.5× 29 652
Katja Hübel Germany 12 486 1.0× 255 1.3× 73 0.8× 16 0.2× 25 0.4× 13 696
Renáta Minorics Hungary 19 377 0.8× 438 2.2× 68 0.7× 212 2.9× 95 1.4× 57 823
Sarah J. West United States 12 207 0.4× 137 0.7× 66 0.7× 111 1.5× 36 0.5× 13 459
Christina Zimmer Germany 18 295 0.6× 396 2.0× 83 0.9× 262 3.6× 59 0.9× 28 914
Dieter Hamprecht United Kingdom 19 616 1.2× 337 1.7× 176 1.8× 20 0.3× 18 0.3× 37 961

Countries citing papers authored by Muriel Duflos

Since Specialization
Citations

This map shows the geographic impact of Muriel Duflos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Duflos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Duflos more than expected).

Fields of papers citing papers by Muriel Duflos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Duflos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Duflos. The network helps show where Muriel Duflos may publish in the future.

Co-authorship network of co-authors of Muriel Duflos

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Duflos. A scholar is included among the top collaborators of Muriel Duflos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Duflos. Muriel Duflos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barillé‐Nion, Sophie, et al.. (2016). Novel 1,6-naphthyridin-2(1H)-ones as potential anticancer agents targeting Hsp90. European Journal of Medicinal Chemistry. 119. 17–33. 18 indexed citations
2.
Marchand, Pascal, Marie‐Renée Nourrisson, Muriel Duflos, et al.. (2013). Efficient New Synthesis of N‐Arylbenzo[b]furo[3,2‐d]pyrimidin‐4‐amines and Their Benzo[b]thieno[3,2‐d]pyrimidin‐4‐amine Analogues via a Microwave‐Assisted Dimroth Rearrangement. Journal of Heterocyclic Chemistry. 50(5). 1187–1197. 7 indexed citations
3.
Marchand, Pascal, Marie‐Renée Nourrisson, Muriel Duflos, et al.. (2012). Synthesis and biological evaluation of N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amines and their pyrido and pyrazino analogues as Ser/Thr kinase inhibitors. European Journal of Medicinal Chemistry. 58. 171–183. 50 indexed citations
4.
Marchand, Pascal, Marie‐Renée Nourrisson, Muriel Duflos, et al.. (2012). Synthesis and biological evaluation of N-aryl-7-methoxybenzo[b]furo[3,2-d]pyrimidin-4-amines and their N-arylbenzo[b]thieno[3,2-d]pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases. European Journal of Medicinal Chemistry. 59. 283–295. 45 indexed citations
5.
6.
7.
Logé, Cédric, Fabrice Pagniez, Véronique Ferchaud‐Roucher, et al.. (2010). Synthesis and in vitro antifungal evaluation of 2-(2,4-difluorophenyl)-1-[(1H-indol-3-ylmethyl)methylamino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols. Journal of Enzyme Inhibition and Medicinal Chemistry. 26(2). 261–269. 15 indexed citations
8.
Giraud, F, et al.. (2010). Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities. Bioorganic & Medicinal Chemistry Letters. 20(17). 5203–5206. 7 indexed citations
9.
Marchand, Pascal, et al.. (2010). A convenient route to functionalized 3-amino-6-bromofuro[3,2-b]pyridine-2-carboxamides. Tetrahedron. 66(25). 4490–4494. 9 indexed citations
10.
Carbonnelle, Delphine, et al.. (2009). A Novel Indole-3-propanamide Exerts Its Immunosuppressive Activity by Inhibiting JAK3 in T Cells. Journal of Pharmacology and Experimental Therapeutics. 331(2). 710–716. 7 indexed citations
11.
Logé, Cédric, et al.. (2009). A convenient synthesis of 5-arylamino-4H-pyran-4-ones using palladium-catalyzed amination. Tetrahedron Letters. 50(41). 5729–5732. 14 indexed citations
12.
Pagniez, Fabrice, et al.. (2007). Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety. Bioorganic & Medicinal Chemistry Letters. 17(13). 3686–3689. 59 indexed citations
13.
Carbonnelle, Delphine, Alexandra Dassonville‐Klimpt, Élise Verron, et al.. (2007). Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents. European Journal of Medicinal Chemistry. 42(5). 686–693. 7 indexed citations
14.
Borgne, Marc Le, Patrícia Recordon-Pinson, Anja Palusczak, et al.. (2005). Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(5). 1134–1137. 61 indexed citations
15.
Dassonville‐Klimpt, Alexandra, et al.. (2004). New N-pyridinyl(methyl)-indolalkanamides acting as topical inflammation inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(21). 5441–5444. 3 indexed citations
16.
Duflos, Muriel, et al.. (2003). New N -Pyridinyl(methyl)-N1-substituted-3-indolepropanamides Acting as Topical and Systemic Anti-inflammatory Agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(2). 201–208. 6 indexed citations
17.
Braud, Emmanuelle, Muriel Duflos, Guillaume Le Baut, et al.. (2003). Potential Inhibitors of Angiogenesis. Part II: 3-(Azolylmethylene)-2,3-dihydrobenzo[b]furan-2-ones. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(3). 253–257. 2 indexed citations
18.
Braud, Emmanuelle, Muriel Duflos, Marie‐Renée Nourrisson, et al.. (2003). Potential Inhibitors of Angiogenesis. Part I: 3-(Imidazol-4(5)-ylmethylene)indolin-2-ones. Journal of Enzyme Inhibition and Medicinal Chemistry. 18(3). 243–252. 8 indexed citations
19.
Duflos, Muriel. (2001). N-Pyridinyl-indole-3-(alkyl)carboxamides and derivatives as potential systemic and topical inflammation inhibitors. European Journal of Medicinal Chemistry. 36(6). 545–553. 51 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Konrad Kubiński Breakdown of academic impact, for papers by Aurélien Lesnard Breakdown of academic impact, for papers by Abid H. Banday Breakdown of academic impact, for papers by Sahar Kandil Breakdown of academic impact, for papers by Eduardo Palomino Breakdown of academic impact, for papers by Katja Hübel Breakdown of academic impact, for papers by Renáta Minorics Breakdown of academic impact, for papers by Sarah J. West Breakdown of academic impact, for papers by Christina Zimmer Breakdown of academic impact, for papers by Dieter Hamprecht
Rankless by CCL
2026